Table 2.

Mean (SD) global CIA score and clinicians' impairment ratings at each assessment and overall, with Spearman's correlation coefficients

Assessment	N	Global CIA score (0–48)	Clinicians' impairment rating (0–6)	rs (p)
Beginning of treatment	23	32.5 (11.1)	4.39 (0.72)	0.692 (<0.001)***
End of treatment	27	7.85 (5.43)	2.11 (1.16)	0.322 (0.102)
20-Week follow-up	22	11.0 (8.87)	1.82 (1.26)	0.454 (0.034)*
40-Week follow-up	25	8.44 (7.08)	1.68 (1.35)	0.471 (0.017)*
60-Week follow-up	18	10.2 (9.10)	1.50 (1.38)	0.590 (0.010)*
2-Year follow-up	16	8.56 (7.50)	1.69 (1.35)	0.633 (0.008)**
3-Year follow-up	6	14.0 (12.1)	2.67 (1.75)	0.924 (0.008)**
Total	137	13.3 (12.1)	2.26 (1.56)	0.676 (<0.001)***

*Significant at 0.05 level.

**Significant at 0.01 level.

***Significant at 0.001 level.